The association between urine response to tolvaptan and hospitalization period in patients with acute heart failure

The association between urine response to tolvaptan and hospitalization period in patients with acute heart failure - Tolvaptan response and hospitalization period

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023594

Enrollment

100

Registered

2016-08-11

Start date

2011-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: This study included consecutive patients who were hospitalized due to acute heart failure and were treated with tolvaptan.

Exclusion criteria

Exclusion criteria: Patients who were already receiving daily tolvaptan before admission and patients with maintenance dialysis were excluded.

Design outcomes

Primary

Measure	Time frame
Clinical profile of responder to tolvaptan	—

Secondary

Measure	Time frame
Patients stay period in CCU and hospital	—

Countries

Japan

Contacts

Public ContactKentaro Jujo

Nishiarai Heart Center Hospital Department of Cardiology

juken1123@mac.com03-5838-0730

Outcome results